Preprint Open Access

Autoepitopes (22 of 27) in rheumatoid arthritis differ from vaccine antigens by a single amino acid residue, ideal for low affinity self reactive T cell mediated autoimmunity and aluminum adjuvant promotes citrullination of vaccine antigens thus the synthesis of ACPA

Arumugham, Vinu

Rheumatoid arthritis (RA) is an autoimmune disorder. Rheumatoid factor (RF) and anti-
citrullinated protein antibodies (ACPA) are known to play a role in RA. RF and ACPA origin is
considered unknown.
Vaccines contain numerous residual proteins of food, animal, plant, fungal and bacterial origin,
from the manufacturing process. Protein sequence analysis shows that 14 of 14 known RF
autoepitopes differ from vaccine antigens by just one amino acid residue. The immune system’s
cancer surveillance system looks for exactly such antigens. Cancer begins with a single DNA
mutation where one base-pair is modified. Proteins encoded by this DNA segment will
therefore also exhibit a single amino acid change. So such peptides with a single amino acid
change (neoantigens) are strong markers for cancer and result in an anti-cancer immune
response, when accompanied by innate immune system co-stimulation. With thousands of such
proteins in vaccines, there is an overwhelming anti-cancer immune response following vaccine
administration. The adjuvant or live virus in the vaccine provides the requisite innate immune
system co-stimulation. Since cancer cells/proteins are very similar to normal cells/proteins,
attacking cancer always carries the risk of autoimmunity (collateral damage). Therefore
vaccines cause numerous autoimmune diseases by triggering unnecessary anti-cancer immune
responses.
In the specific case of RF, the target is the immune system’s IgG antibody itself. The immune
system produces IgM antibodies (RF) that bind to the IgG antibody. Since this is a case of the
immune system attacking its own “soldiers” (friendly fire), it weakens the immune system’s
ability to fight cancer or infections.
Aluminum adjuvant in vaccines promotes citrullination of the antigens. Therefore the immune
system produces antibodies against the regular and citrullinated versions of the antigen. The
antibodies synthesized against citrullinated antigens (anti citrullinated protein antibodies
(ACPA)) play a major role in RA.
The solution is to immediately remove all non-target antigens from all vaccines and injections.
 

Files (132.9 kB)
Name Size
rheumatoidArthritis.pdf
md5:77e5af79fde7111ba4b0a36fe410195e
132.9 kB Download
636
126
views
downloads
All versions This version
Views 636636
Downloads 126126
Data volume 16.7 MB16.7 MB
Unique views 627627
Unique downloads 122122

Share

Cite as